Danaher Corporation (BIT:1DHR)

Market Cap	117.55B
Revenue (ttm)	23.06B
Net Income (ttm)	3.77B
Shares Out	n/a
EPS (ttm)	5.11
PE Ratio	31.21
Forward PE	n/a
Dividend	1.00 (0.62%)
Ex-Dividend Date	Dec 24, 2024

Volume	n/a
Average Volume	1
Open	161.26
Previous Close	161.26
Day's Range	161.26 - 161.26
52-Week Range	159.04 - 261.90
Beta	n/a
RSI	25.93
Earnings Date	Apr 22, 2025

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manuf...

• Industry: Laboratory Analytical Instruments
• Founded: 1969
• Employees: 63,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1DHR

Financial Performance

In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.

Financial numbers in USD